Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olmesartan Add-on to Amlodipine in Hypertension
NCT00220233Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of olmesartan in essential hypertension, sponsored by Daiichi Sankyo Co., Ltd.. Started Apr 2005; status: completed.
02
Drugs
olmesartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00220233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00220233.